Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco

Paolo Lenzi, Nunzia Scotti, Fiammetta Alagna, Maria L. Tornesello, Andrea Pompa, Alessandro Vitale, Angelo De Stradis, Luigi Monti, Stefania Grillo, Franco M. Buonaguro, Pal Maliga, Teodoro Cardi

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of death for women. The major capsid L1 protein self-assembles in Virus Like Particles (VLPs), which are highly immunogenic and suitable for vaccine production. In this study, a plastid transformation approach was assessed in order to produce a plant-based HPV-16 L1 vaccine. Transplastomic plants were obtained after transformation with vectors carrying a chimeric gene encoding the L1 protein either as the native viral (L1 v gene) or a synthetic sequence optimized for expression in plant plastids (L1pt gene) under control of plastid expression signals. The L1 mRNA was detected in plastids and the L1 antigen accumulated up to 1.5% total leaf proteins only when vectors included the 5prime;-UTR and a short N-terminal coding segment (Downstream Box) of a plastid gene. The half-life of the engineered L1 protein, determined by pulse-chase experiments, is at least 8 h. Formation of immunogenic VLPs in chloroplasts was confirmed by capture ELISA assay using antibodies recognizing conformational epitopes and by electron microscopy.

Original languageEnglish
Pages (from-to)1091-1102
Number of pages12
JournalTransgenic Research
Volume17
Issue number6
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Plastids
Papillomaviridae
Capsid Proteins
Chloroplasts
coat proteins
plastids
Tobacco
tobacco
chloroplasts
antigens
Antigens
virus-like particles
Virion
Genes
Vaccines
genes
Leukocyte L1 Antigen Complex
Human papillomavirus 16
vaccines
Untranslated Regions

Keywords

  • HPV16
  • L1
  • Nicotiana tabacum
  • Plant vaccines
  • Plastid transformation
  • Tobacco

ASJC Scopus subject areas

  • Biotechnology
  • Genetics
  • Agronomy and Crop Science
  • Animal Science and Zoology

Cite this

Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. / Lenzi, Paolo; Scotti, Nunzia; Alagna, Fiammetta; Tornesello, Maria L.; Pompa, Andrea; Vitale, Alessandro; De Stradis, Angelo; Monti, Luigi; Grillo, Stefania; Buonaguro, Franco M.; Maliga, Pal; Cardi, Teodoro.

In: Transgenic Research, Vol. 17, No. 6, 12.2008, p. 1091-1102.

Research output: Contribution to journalArticle

Lenzi, Paolo ; Scotti, Nunzia ; Alagna, Fiammetta ; Tornesello, Maria L. ; Pompa, Andrea ; Vitale, Alessandro ; De Stradis, Angelo ; Monti, Luigi ; Grillo, Stefania ; Buonaguro, Franco M. ; Maliga, Pal ; Cardi, Teodoro. / Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. In: Transgenic Research. 2008 ; Vol. 17, No. 6. pp. 1091-1102.
@article{3a5e452e88804223a9a53891df124280,
title = "Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco",
abstract = "Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of death for women. The major capsid L1 protein self-assembles in Virus Like Particles (VLPs), which are highly immunogenic and suitable for vaccine production. In this study, a plastid transformation approach was assessed in order to produce a plant-based HPV-16 L1 vaccine. Transplastomic plants were obtained after transformation with vectors carrying a chimeric gene encoding the L1 protein either as the native viral (L1 v gene) or a synthetic sequence optimized for expression in plant plastids (L1pt gene) under control of plastid expression signals. The L1 mRNA was detected in plastids and the L1 antigen accumulated up to 1.5{\%} total leaf proteins only when vectors included the 5prime;-UTR and a short N-terminal coding segment (Downstream Box) of a plastid gene. The half-life of the engineered L1 protein, determined by pulse-chase experiments, is at least 8 h. Formation of immunogenic VLPs in chloroplasts was confirmed by capture ELISA assay using antibodies recognizing conformational epitopes and by electron microscopy.",
keywords = "HPV16, L1, Nicotiana tabacum, Plant vaccines, Plastid transformation, Tobacco",
author = "Paolo Lenzi and Nunzia Scotti and Fiammetta Alagna and Tornesello, {Maria L.} and Andrea Pompa and Alessandro Vitale and {De Stradis}, Angelo and Luigi Monti and Stefania Grillo and Buonaguro, {Franco M.} and Pal Maliga and Teodoro Cardi",
year = "2008",
month = "12",
doi = "10.1007/s11248-008-9186-3",
language = "English",
volume = "17",
pages = "1091--1102",
journal = "Transgenic Research",
issn = "0962-8819",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco

AU - Lenzi, Paolo

AU - Scotti, Nunzia

AU - Alagna, Fiammetta

AU - Tornesello, Maria L.

AU - Pompa, Andrea

AU - Vitale, Alessandro

AU - De Stradis, Angelo

AU - Monti, Luigi

AU - Grillo, Stefania

AU - Buonaguro, Franco M.

AU - Maliga, Pal

AU - Cardi, Teodoro

PY - 2008/12

Y1 - 2008/12

N2 - Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of death for women. The major capsid L1 protein self-assembles in Virus Like Particles (VLPs), which are highly immunogenic and suitable for vaccine production. In this study, a plastid transformation approach was assessed in order to produce a plant-based HPV-16 L1 vaccine. Transplastomic plants were obtained after transformation with vectors carrying a chimeric gene encoding the L1 protein either as the native viral (L1 v gene) or a synthetic sequence optimized for expression in plant plastids (L1pt gene) under control of plastid expression signals. The L1 mRNA was detected in plastids and the L1 antigen accumulated up to 1.5% total leaf proteins only when vectors included the 5prime;-UTR and a short N-terminal coding segment (Downstream Box) of a plastid gene. The half-life of the engineered L1 protein, determined by pulse-chase experiments, is at least 8 h. Formation of immunogenic VLPs in chloroplasts was confirmed by capture ELISA assay using antibodies recognizing conformational epitopes and by electron microscopy.

AB - Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of death for women. The major capsid L1 protein self-assembles in Virus Like Particles (VLPs), which are highly immunogenic and suitable for vaccine production. In this study, a plastid transformation approach was assessed in order to produce a plant-based HPV-16 L1 vaccine. Transplastomic plants were obtained after transformation with vectors carrying a chimeric gene encoding the L1 protein either as the native viral (L1 v gene) or a synthetic sequence optimized for expression in plant plastids (L1pt gene) under control of plastid expression signals. The L1 mRNA was detected in plastids and the L1 antigen accumulated up to 1.5% total leaf proteins only when vectors included the 5prime;-UTR and a short N-terminal coding segment (Downstream Box) of a plastid gene. The half-life of the engineered L1 protein, determined by pulse-chase experiments, is at least 8 h. Formation of immunogenic VLPs in chloroplasts was confirmed by capture ELISA assay using antibodies recognizing conformational epitopes and by electron microscopy.

KW - HPV16

KW - L1

KW - Nicotiana tabacum

KW - Plant vaccines

KW - Plastid transformation

KW - Tobacco

UR - http://www.scopus.com/inward/record.url?scp=54949157827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54949157827&partnerID=8YFLogxK

U2 - 10.1007/s11248-008-9186-3

DO - 10.1007/s11248-008-9186-3

M3 - Article

C2 - 18491213

AN - SCOPUS:54949157827

VL - 17

SP - 1091

EP - 1102

JO - Transgenic Research

JF - Transgenic Research

SN - 0962-8819

IS - 6

ER -